A Study of IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Clinical trial NCT03528629 · COMPLETED
Trial details
- NCT number
- NCT03528629
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-08
- Primary completion
- 2020-06-09
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.